Table 1.
Variants | Nextstrain clade | First identified | Spike protein mutations | Characteristics |
---|---|---|---|---|
Alpha | 20I/501Y.V1 | UK | ΔH69, ΔV70, Δ144, (E484K*), (S494P*), N501Y, A570D, D614G, P681H, T716I, S982A, D1118H (K1191N*) | Rapid transmissibility and higher infectivity |
Beta | 20H/501.V2 | South Africa | D80A, D215G, Δ241, Δ242, Δ243, V367F, P384L, R408I, K417N, E484K, N501Y, D614G, A701V | Higher viral infectivity and immune escape |
Gamma | 20J/501Y.V3 | Japan/Brazil | L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F | Augment of viral transmissibility |
Delta | 21A/S:478K | India | T19R, (V70F*), T95I, G142D, E156-, F157-, R158G, (A222V*), (W258L*), (K417N*), L452R, T478K, D614G, P681R, D950N | Most contagious; higher viral replication; and leading to severe illness |
Delta plus | NA | India | T95I, G142D, R158G, L452R, T478K, K417N | Increased transmissibility; high affinity with pulmonary epithelial cells; and immune evasion |
Omicron | 21K | South Africa | A67V, ΔH69, ΔV70, T95I, G142D, ΔV143, ΔY144, ΔY145, ΔN211, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K, L981F, and N856K | Increased viral replication, infectivity and re-infection; increased transmissibility; immune escape; recombination with HCoV-229E viruses |
UK, United Kingdom; Δ, deletion; ins, insertion; *, detected in some sequences but not all; NA, not available. The bold values show the shared mutation in all variants.